These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17223774)

  • 21. [Effects of the RALE study. Hyperkalemia following spironolactone treatment].
    Erdmann E
    Internist (Berl); 2005 Apr; 46(4):466, 468. PubMed ID: 15723149
    [No Abstract]   [Full Text] [Related]  

  • 22. Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study.
    Kasje WN; Denig P; Stewart RE; de Graeff PA; Haaijer-Ruskamp FM
    Eur J Clin Pharmacol; 2005 Apr; 61(2):145-51. PubMed ID: 15761751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ACE inhibitor therapy: benefits and underuse.
    Smith SC
    Am Fam Physician; 1999 Jan; 59(1):35-6, 38. PubMed ID: 9917572
    [No Abstract]   [Full Text] [Related]  

  • 24. Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure. Effect of physician specialty and patient characteristics.
    Chin MH; Wang JC; Zhang JX; Lang RM
    J Gen Intern Med; 1997 Sep; 12(9):563-6. PubMed ID: 9294790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The use of angiotensin-converting enzyme inhibitors in anterior infarct without congestive symptoms. The arguments pro].
    de Teresa E
    Rev Esp Cardiol; 1994 Nov; 47(11):723-8. PubMed ID: 7800901
    [No Abstract]   [Full Text] [Related]  

  • 26. [The use of angiotensin-converting enzyme inhibitors in anterior infarct without congestive symptoms. The arguments contra].
    Rodríguez Lambert JL; Moris C
    Rev Esp Cardiol; 1994 Nov; 47(11):719-22. PubMed ID: 7800900
    [No Abstract]   [Full Text] [Related]  

  • 27. Prescribing and emergency admissions for heart failure in greater Glasgow.
    Davie AP; Morrison CE; Forrester JE; Mcmurray JJ
    J Card Fail; 1999 Mar; 5(1):3-7. PubMed ID: 10194654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACE inhibitors: myocardial infarction and congestive heart failure.
    Cody RJ
    Am Fam Physician; 1995 Nov; 52(6):1801-6. PubMed ID: 7484690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of angiotensin converting enzyme inhibitors for the treatment of patients with left ventricular dysfunction, heart failure or after acute myocardial infarction.
    Swedberg K; Sharpe N
    Eur Heart J; 1996 Sep; 17(9):1306-11. PubMed ID: 8880014
    [No Abstract]   [Full Text] [Related]  

  • 30. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modern management of hypertension and heart failure: evidence and practice.
    Hobbs FD
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i35-8; discussion i50. PubMed ID: 10956320
    [No Abstract]   [Full Text] [Related]  

  • 32. ACE inhibitors after myocardial infarction.
    Poole-Wilson PA
    Lancet; 1994 Jan; 343(8892):289-90. PubMed ID: 7905109
    [No Abstract]   [Full Text] [Related]  

  • 33. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals.
    Philbin EF; Andreaou C; Rocco TA; Lynch LJ; Baker SL
    Am J Cardiol; 1996 Apr; 77(10):832-8. PubMed ID: 8623735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart failure after myocardial infarction: A good heart is hard to find.
    Velazquez EJ; O'Connor CM
    Am Heart J; 1999 Dec; 138(6 Pt 1):1009-11. PubMed ID: 10577426
    [No Abstract]   [Full Text] [Related]  

  • 35. Heart failure and angiotensin-converting enzyme inhibitors: towards evidence-based health care.
    Cowie MR; Hardman SM
    Br J Hosp Med; 1995 Mar 1-14; 53(5):186-8. PubMed ID: 7749547
    [No Abstract]   [Full Text] [Related]  

  • 36. Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure.
    McClellan MB; Loeb JM; Clancy CM; Francis GS; Jacobs AK; Kizer KW; O'Kane ME; Wolk MJ
    Ann Intern Med; 2005 Mar; 142(5):386-7; author reply 388-9. PubMed ID: 15738459
    [No Abstract]   [Full Text] [Related]  

  • 37. Heart failure complicating acute myocardial infarction.
    Aronow WS
    Clin Geriatr Med; 2000 Aug; 16(3):535-48. PubMed ID: 10918646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACE inhibitors after myocardial infarction.
    Jackson G
    Br J Clin Pract; 1995; 49(4):171. PubMed ID: 7547152
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapy of heart failure after myocardial infarction. With eplerenone a new course].
    MMW Fortschr Med; 2004 Oct; 146(43):58-9. PubMed ID: 15559524
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of angiotensin-converting enzyme inhibitors in the treatment and prevention of congestive heart failure.
    Toher CA; Francis GS
    Coron Artery Dis; 1993 Jan; 4(1):37-43. PubMed ID: 8269182
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.